Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial.

Saved in:
Bibliographic Details
Title: Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial.
Authors: Khanani AM; Sierra Eye Associates, Reno, Nevada; University of Nevada, Reno School of Medicine, Reno, Nevada. Electronic address: arshad.khanani@gmail.com., Danzig CJ; Department of Surgery, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida., Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts., Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina., Kaiser PK; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Lally DR; New England Retina Consultants, Springfield, Massachusetts., Patel SS; West Texas Retina Consultants, Abilene, Texas., Vajzovic L; Department of Ophthalmology, Duke University, Durham, North Carolina., Weng CY; Department of Ophthalmology, Baylor College of Medicine, Houston, Texas., Patel H; Astellas Pharma Inc., Northbrook, Illinois., Clark J; Astellas Pharma Inc., Northbrook, Illinois., Desai D; Astellas Pharma Inc., Northbrook, Illinois., Luo D; Astellas Pharma Inc., Northbrook, Illinois., Henry E; Astellas Pharma Inc., Northbrook, Illinois., Holz FG; Department of Ophthalmology, University of Bonn, Bonn, Germany.
Corporate Authors: GATHER2 Trial Investigators
Source: Ophthalmology [Ophthalmology] 2026 Apr; Vol. 133 (4), pp. 451-465. Date of Electronic Publication: 2025 Dec 15.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1549-4713
DOI:10.1016/j.ophtha.2025.12.011